Whitehawk Therapeutics (WHWK)

• Market cap: $116M
• 1 day: 2.5%
• 5 days: 4.24%
• 1 month: 28.13%
• 3 months: 38.98%
• 6 months: 67.35%
• Year to date: -21.66%
• 1 year: 23.62%
• 5 years: -87.76%
• 10 years: -95.79%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 21